Table 4.
Variable | Reference Group | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|
Hazard Ratio (95% CI) | p-value | p-value for Variable | Hazard Ratio | p-value | p-value for Variable | ||
Year of ART initiation | |||||||
1998–2000 | 2007–2008 | 3.21 (2.17 – 4.73) | <0.0001 | <0.0001 | 2.17 (0.92 – 5.15) | 0.0781 | 0.1794 |
2001–2002 | 2007–2008 | 1.27 (0.88 – 1.84 | 0.1942 | 0.87 (0.47 – 1.62) | 0.6634 | ||
2003–2004 | 2007–2008 | 1.54 (1.30 – 1.82) | <0.0001 | 0.94 (0.75 – 1.18) | 0.6013 | ||
2005–2006 | 2007–2008 | 1.24 (1.04 – 1.47) | 0.0151 | 1.05 (0.85 – 1.31) | 0.6240 | ||
ART regimen | |||||||
PI regimen | NNRTI | 0.88 (0.71 – 1.10) | 0.2675 | 0.3164 | N/A | N/A | N/A |
Other regimen | NNRTI | 1.24 (0.81 – 1.92) | 0.3259 | N/A | N/A | N/A | |
Site | |||||||
Barbados | Haiti | 0.91 (0.72 – 1.14) | 0.4209 | <0.0001 | 1.95 (1.37 – 2.76) | 0.0002 | <0.0001 |
Dominican Republic | Haiti | 1.40 (1.18 – 1.66) | <0.0001 | 1.72 (1.34 – 2.21) | <0.0001 | ||
Jamaica | Haiti | 0.58 (0.42 – 0.80) | 0.0010 | 0.88 (0.52 – 1.47) | 0.6183 | ||
Martinique | Haiti | 0.43 (0.28 – 0.67) | 0.0002 | 1.03 (0.63 – 1.70) | 0.8936 | ||
Puerto Rico | Haiti | 1.59 (1.17 – 2.18) | 0.0033 | 2.25 (1.04 – 4.87) | 0.0389 | ||
Trinidad | Haiti | 0.68 (0.53 – 0.86) | 0.0013 | 0.82 (0.60 – 1.12) | 0.2060 | ||
Age at ART initiation | Unit = 10 years | 1.13 (1.07 – 1.20) | <0.0001 | 1.19 (1.11 – 1.28) | <0.0001 | ||
Gender | Female | 1.22 (1.08 – 1.38) | 0.0014 | 1.58 (1.33 – 1.87) | <0.0001 | ||
Intravenous drug use | None | 1.40 (1.05 – 1.86) | 0.0220 | 1.32 (0.85 – 2.05) | 0.2119 | ||
Baseline weight | Unit = 10 pounds | 0.84 (0.82 – 0.87) | <0.0001 | 0.85 (0.82 – 0.89) | <0.0001 | ||
Baseline hemoglobin | Unit = 1 g/dl | 0.82 (0.79 – 0.85) | <0.0001 | 0.84 (0.80 – 0.88) | <0.0001 | ||
Baseline CD4 cell count | Unit = 50 cells/ml | 0.88 (0.85 – 0.91) | <0.0001 | 0.90 (0.86 – 0.93) | <0.0001 | ||
TB and ART Co-Treatment | No TB | 1.84 (1.53 – 2.21) | <0.0001 | 1.58 (1.25 – 2.01) | 0.0002 |